In a study published in Nature on October 23, Conor Liston, MD, PhD, and his collaborators present new results, using mouse models, on the effects of depleted gut microbiota on the brain.
Dr. Randy Longman, MD, PhD, (Tri-I MD-PhD graduating class of 2007) has been named as the new Director of the Jill Roberts Center for Inflammator Bowel Disease at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center.
José Trevejo, MD, PhD, (Tri-I graduating class of 2001), was interviewed by the Massachusetts Biotechnology Council on his background, career, education, and the need for more Hispanic and Latino/a in STEM fields and biotech, particularly in leadership positions.Dr. Trevejo is currently the CEO and Co-FOunder of Smartpharm Therapeutics in Boston.
Dr. Ronald Koenig, Tri-Instutional MD-PhD graduating class 1978, has been selected to receive the Lifetime Achievement Award in Medical Education from Michigan Medicine, where he has been a member of the faculty since 1988 and the director of their MSTP since 1995.
Rosalind Segal, MD, PhD, (Tri-Institutional MD-PhD graduating class of 1986), has been named as the Dean of Graduate Education at Harvard Medical School. Her post begins today, August 1, 2019.Dr. Segal, who has led a research lab at the Dana-Farber Cancer Center since 1998, will assume her new post while continuing her post as professor of neurobiology at HMS and leading the work of her lab.
RAPT Therapeutics, Inc. (formerly called FLX Bio Inc.) raised more than $86 million in its initial public offering earlier this month. Brian Wong, M.D., Ph.D., (Tri-Institutional MD-PhD graduating class of 2001) leads RAPT as both President and CEO of the company.
Professor Barbara Kazmierczak, MD, PhD (Tri-Institutional MD-PhD class of 1994), who currently is professor of medicine (infectious diseases) and microbial pathogenesis, has been named the Gustavus and Louse Pfeiffer Research Foundation MD-PhD Program Director at the Yale School of Medicine.